MedPacto, Inc.
Develops first-in-class therapies for oncology and autoimmune diseases.
235980 | KO
Overview
Corporate Details
- ISIN(s):
- KR7235980000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 명달로 92, 보림빌딩, 서초구
- Website:
- http://www.medpacto.com/eng/
- Sector:
- Manufacturing
Description
MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-28 00:00 |
[기재정정]정기주주총회결과
|
Korean | 30.0 KB | ||
| 2023-03-14 00:00 |
사업보고서 (2022.12)
|
Korean | 1.3 MB | ||
| 2023-03-13 00:00 |
감사보고서제출
|
Korean | 25.1 KB | ||
| 2023-03-09 00:00 |
기타경영사항(자율공시)(특허권 취득)
|
Korean | 6.5 KB | ||
| 2023-03-09 00:00 |
[기재정정]기타경영사항(자율공시)(특허권 취득)
|
Korean | 9.5 KB | ||
| 2023-03-08 00:00 |
주주총회소집공고
|
Korean | 196.6 KB | ||
| 2023-03-08 00:00 |
의결권대리행사권유참고서류
|
Korean | 188.1 KB | ||
| 2023-03-07 00:00 |
주주총회소집결의
|
Korean | 15.7 KB | ||
| 2023-02-15 00:00 |
투자판단관련주요경영사항(재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS…
|
Korean | 9.8 KB | ||
| 2023-02-10 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB | ||
| 2023-02-10 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2023-01-18 00:00 |
기타경영사항(자율공시)(만성 골수성 백혈병 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법에 관한 특허권 취득)
|
Korean | 6.4 KB | ||
| 2023-01-16 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득(제4회차 CB)
|
Korean | 10.4 KB | ||
| 2022-12-28 00:00 |
투자판단관련주요경영사항(전이성 위암 환자 대상 2차 치료로써 백토서팁과 파클리탁셀 병용 요법의 내약성 및 안전성을 평가하는 1b/2a상 임상 …
|
Korean | 16.1 KB | ||
| 2022-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all MedPacto, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MedPacto, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MedPacto, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
